News & Events

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorkers, according to a viewpoint article published in JAMA Oncology on Aug. 13 by Weill Cornell Medicine and NewYork-Presbyterian investigators. The authors write that higher rates of SARS-CoV-2 infection among Blacks and Hispanics will lead to delays...

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms? The multidisciplinary team will seek to identify underlying genetic and immune factors that contribute to these varying outcomes to help guide the development of precision prevention and treatment efforts.

The ...

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a ...

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian. The findings provide new insights into the relationship between viral load and the risk of severe illness in both populations and may help guide treatment decisions.

The researchers, whose ...

New York, NY – NewYork Quality Care, the accountable care organization (ACO) of NewYork-Presbyterian, Columbia University Irving Medical Center, and Weill Cornell Medicine, saved Medicare $23,288,625 in 2019 and improved the quality of care for Medicare beneficiaries, according to performance results recently released by the Centers for Medicare & Medicaid Services (CMS). The three...

Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research. 

Investigators at Weill Cornell Medicine are leading three of the six projects, which range from $150,000 and $370,000 in...

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19, a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian has found. The findings suggest that in the absence of other risk factors for poor COVID-19 outcomes, patients with cancer may be able to safely continue treatment during the pandemic. It is important to weigh the risk of severe COVID-19 illness against the risk of delaying...

Weill Cornell Medicine and NewYork-Presbyterian investigators have built a machine-learning tool that can predict SARS-CoV-2 infection based on age, gender, race and 27 routine laboratory test results. The innovation holds potential for identifying high-risk patients infected by the virus within two hours, much sooner than waiting 24 hours or longer for standard RT-PCR test results from nasal/throat swabs. Faster identification could allow physicians to isolate and treat infected patients...